Metropolitan Life Insurance Company (MetLife)’s Credo Technology Group CRDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,572
| Closed | -$139K | – | 500 |
|
|
2024
Q1 | $139K | Buy |
6,572
+9
| +0.1% | +$191 | 0.01% | 880 |
|
|
2023
Q4 | $128K | Buy |
6,563
+851
| +15% | +$16.6K | 0.01% | 955 |
|
|
2023
Q3 | $87.1K | Buy |
5,712
+405
| +8% | +$6.18K | ﹤0.01% | 1089 |
|
|
2023
Q2 | $92K | Buy |
+5,307
| New | +$92K | ﹤0.01% | 1056 |
|
|
2023
Q1 | – | Sell |
-6,017
| Closed | -$80.1K | – | 2344 |
|
|
2022
Q4 | $80.1K | Hold |
6,017
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q3 | $66.2K | Buy |
6,017
+4,326
| +256% | +$47.6K | ﹤0.01% | 1273 |
|
|
2022
Q2 | $19.8K | Hold |
1,691
| – | – | ﹤0.01% | 2059 |
|
|
2022
Q1 | $25.8K | Buy |
+1,691
| New | +$25.8K | ﹤0.01% | 1972 |
|